Medicamen Biotech Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Medicamen Biotech Company Profile :

MEDICAMEN Biotech Limited is an Indian company engaged in the business of manufacturing of pharmaceutical formulations.

Company is a manufacturer and supplier of a range of products, such as tablets, capsules, liquid syrup and dry syrup (beta lactum and non-beta lactum), ointment and oral rehydration solution (ORS).

Company has two finished formulation plants, one at Bhiwadi (Rajasthan) and other at Haridwar (Uttarakhand).


Medicamen Biotech ResultsBSE Code : 531146
NSE Symbol :
ISIN No. : INE646B01010
Industry :  Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Medicamen Biotech or you are an stock market analyst then i am sure you might for Quarterly Results of Medicamen Biotech.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Medicamen Biotech. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Medicamen Biotech.

Medicamen Biotech Q1 Results 2016-17 :

Medicamen Biotech will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure  –
Interest  –
Depreciation
PBT  –
Tax
Net Profit
Equity
EPS  –

Medicamen Biotech will announce its Q2 FY 2016-17 Results in the month of October 2016.

Medicamen Biotech will announce its Q3 FY 2016-17 Results in the month of January 2017.

Medicamen Biotech will announce its Q4 FY 2016-17 Results in the month of April 2017.

Medicamen Biotech will announce its FY 2016-17 Results in the month of April 2017.

Note : We will update the results table above as and when results are announced. Visit again.

Medicamen Biotech Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 67.28
Other Income  0.70
Total Income  67.98
Expenditure  -62.27
Interest -3.10
Depreciation -1.90
PBT 0.71
Tax -0.23
Net Profit 0.48  –
Equity 9.99
EPS 0.48

Note : If you like this information about Medicamen Biotech Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.